Mr. Pascal Soriot's most recent trade in Astrazeneca plc was a trade of 60,000 Ords done at an average price of $121.0 . Disclosure was reported to the exchange on Sept. 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 14 Sep 2026 | 60,000 | 430,428 (0%) | 0% | 121.0 | 7,261,200 | Ords | |
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 14 May 2026 | 18,359 | 370,428 (0%) | 0% | 0 | Ords 0.25p | ||
| Agilent Tech | Mr. Pascal Soriot | Director | Grant, award, or other acquisition of securities at price $ 111.75 per share. | 19 Mar 2026 | 2,158 | 3,331 (0%) | 0% | 111.8 | 241,157 | Common Stock |
| Agilent Tech | Mr. Pascal Soriot | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.75 per share. | 19 Mar 2026 | 648 | 2,683 (0%) | 0% | 111.8 | 72,414 | Common Stock |
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 05 Mar 2026 | 101,495 | 352,069 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 04 Mar 2026 | 14,967 | 250,574 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 522,935 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 07 Nov 2025 | 136,537 | 386,398 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 21 May 2025 | 8,970 | 386,398 (0%) | 0% | 0 | Ords 0.25p | ||
| Agilent Tech | Mr. Pascal Soriot | Director | Grant, award, or other acquisition of securities at price $ 108.91 per share. | 21 May 2025 | 1,677 | 1,677 (0%) | 0% | 108.9 | 182,642 | Common Stock |
| Agilent Tech | Mr. Pascal Soriot | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.91 per share. | 21 May 2025 | 504 | 1,173 (0%) | 0% | 108.9 | 54,891 | Common Stock |
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 06 Mar 2025 | 89,962 | 377,428 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 05 Mar 2025 | 248 | 287,466 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 04 Mar 2025 | 17,357 | 287,218 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 14 Nov 2024 | 20,000 | 221,356 (0%) | 0% | 102.0 | 2,040,600 | Ords 0.25p | |
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 10 Jun 2024 | 297,418 | 201,356 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 08 Mar 2024 | 105,238 | 498,774 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 05 Mar 2024 | 17,702 | 393,536 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 20 Feb 2024 | 12,345 | 375,834 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 23 Mar 2023 | 138,093 | 325,971 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 06 Mar 2023 | 8,853 | 187,878 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 09 Feb 2023 | 15,187 | 179,025 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 24 Mar 2022 | 129,784 | 163,838 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 08 Mar 2022 | 9,930 | 34,054 (0%) | 0% | 0 | - | ||
| Astrazeneca plc | Mr. Pascal Soriot | Executive Director,Chief Executive Officer | 10 Feb 2022 | 24,124 | 24,124 (0%) | 0% | 0 | - |